According to filings with the U.S. Securities and Exchange Commission, Sepragen is raising up to $5,000,000.00 in new funding. Sources indicate that as part of senior management President, Vinit Saxena played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Sepragen
Sepragen Corporation is based in Union City, California. We are passionate about making a positive difference in the lives of people by providing state of the art equipment used in the manufacture of life saving biological drugs and vaccines. Our products are used by industry leaders across four continents in the manufacturing of 24 FDA approved drugs and 100s of millions of doses of two well known Covid-19 vaccines, a capacity increase we enabled in 14 weeks! Sepragens best in class equipment enable rapid scale up from lab to production scale often in existing small footprint facilities without impacting Capex and time to market. The growing suite of products include small footprint chromatography columns, innovative standard, single-use and continuous chromatography systems, buffer making systems, and cutting edge integrated Chromatography and buffer making systems as well as novel bioreactors. We are committed to bringing our customers products that deliver many times higher performance for the same investment in money, time and infrastructure all within the framework of quality, compliance and exceptional support. Our world class products are backed by an exceptional team of high performance and committed individuals- all focused on one thing: Delivering on what we promise! .

To learn more about Sepragen, visit http://www.sepragen.com/
Sepragen Linkedin Page: https://www.linkedin.com/company/sepragen-corporation/

Contact:
Vinit Saxena, President
510-475-0650
https://www.linkedin.com/in/vinit-saxena-7889a/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.